Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. - Wikidata - awgldk - TriplyDB

Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.

Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q30392056

about

Hepatitis B and concomitant hepatic steatosis.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease.Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case-control study in Eastern Chinese Han population.Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation.Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome.

P2860

Q39157327-1D3B5FCF-777B-4B75-8E89-E02B14E80D21 Q50190669-BDC12EB5-7131-4561-98BB-691AD4071272 Q51244039-AA3DDEDB-64B9-4639-8C84-F868716A1499 Q52724124-3B7AEDB5-AF9E-41AF-B1BD-5723E3E7D912 Q55028557-94D100B5-5982-4ADD-AF8D-A5D38D7A3531 Q55122484-C887C16E-8923-42FD-8864-3B17468E89F1 Q55167357-33E8E8DF-5762-46EE-BC26-1CF66FC0183A

P2860

Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q30392056

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Concurrent fatty liver increas ...... ents with chronic hepatitis B.

@ast

Concurrent fatty liver increas ...... ents with chronic hepatitis B.

@en

type

label

Concurrent fatty liver increas ...... ents with chronic hepatitis B.

@ast

Concurrent fatty liver increas ...... ents with chronic hepatitis B.

@en

prefLabel

Concurrent fatty liver increas ...... ents with chronic hepatitis B.

@ast

Concurrent fatty liver increas ...... ents with chronic hepatitis B.

@en

P1433

Q30392056-CCEE0D62-E46F-4C73-AA13-6E431C5A9FF0

P1476

Q30392056-ADDBEE71-4BDC-425F-B64F-8D069F8F5AE5

P2093

Q30392056-2FCD40B2-BEA5-4983-B0AE-5094F69DBC10

Q30392056-441AA121-5EB1-415D-B85C-8DE505D28C9F

Q30392056-455780D0-116B-42B5-BAF9-38473865159B

Q30392056-48B2CA2D-03F4-4775-9443-841A474DE12F

Q30392056-4F48974F-20F4-42DF-9B1C-02876E2F678D

Q30392056-605D56F4-33E8-4298-B825-32B78F03EA92

Q30392056-7F826946-51BF-43FE-9464-D0ADDA7E9683

Q30392056-D98F2730-5441-4AB1-A930-3658B2859A1F

P2860

Q30392056-0B83B4A3-84C1-4C0E-8C1F-0191F22F0406

Q30392056-0C2F5ACD-8FA0-4971-8407-6831BAA5F6DE

Q30392056-0DAFAE4E-DECC-4F94-9D63-79A3269D2B35

Q30392056-16F01D4E-A8C9-4128-BEB9-E79BF08665BF

Q30392056-189AE097-7A58-46BB-B638-14201B6A4853

Q30392056-18F2A226-8391-495D-BD4E-A0C37D7FF99E

Q30392056-22CDAADB-4701-4070-932D-F129E81A8E2D

Q30392056-28D18D67-BF27-480E-B1DC-2DC6848C2A69

Q30392056-2DA531D3-1836-4477-AC51-B76CE6EBFA1D

Q30392056-2FE50ABA-C86D-4042-B679-E5127FBD1103

P304

Q30392056-539DE4E5-DE94-47BF-9683-01C84C02AFC3

P31

Q30392056-6A061034-915D-41EB-8FA3-8B29009C1847

P356

Q30392056-41B0295B-DC57-451E-80D7-457B6F80FEBE

P433

Q30392056-F8C0E48F-4729-4442-B6BC-CC9447587042

P478

Q30392056-33B8C98B-6B29-41CB-AC59-C0658F6A41AD

P50

Q30392056-F535B39C-41F6-4088-B0D4-916BF3AC8C52

P577

Q30392056-5069AD73-D67F-464A-BCA6-C1903E8A15A9

P698

Q30392056-9F29132B-05EF-403A-8EE1-6A0E21C23CB7

P356

P1433

Journal of Gastroenterology and Hepatology

P1476

Concurrent fatty liver increas ...... ients with chronic hepatitis B

@en

P2093

Grace L H Wong

http://www.w3.org/2001/XMLSchema#string

Henry L Y Chan

http://www.w3.org/2001/XMLSchema#string

Hoi-Yun Chan

http://www.w3.org/2001/XMLSchema#string

Joanna H M Tong

http://www.w3.org/2001/XMLSchema#string

Ka-Fai To

http://www.w3.org/2001/XMLSchema#string

Paul C L Choi

http://www.w3.org/2001/XMLSchema#string

Vincent W S Wong

http://www.w3.org/2001/XMLSchema#string

Yau-Hei Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Histological grading and staging of chronic hepatitis

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Comparative proteomic profiles indicating genetic factors may involve in hepatocellular carcinoma familial aggregation.

P304

667-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JGH.13536

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Anthony Wing-Hung Chan

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27547913

http://www.w3.org/2001/XMLSchema#string